Literature DB >> 11383750

On individual preferences and aggregation in economic evaluation in healthcare.

B Liljas1, B Lindgren.   

Abstract

For practical reasons, in order to carry out economic evaluations of collective decisions, total costs will generally be compared with total benefits; hence, individuals' willingness to pay (WTP) or quality-adjusted life-years (QALYs) have to be estimated at an aggregate level. So far, aggregation has usually been done by taking the individuals' mean WTP or the unweighted number of QALYs. Since the aggregation process is closely related to the way that income, health and/or utility of different individuals are compared and weighted, it also has significant equity implications. Thus. the explicit (or, more often, implicit) assumptions behind the aggregation process will largely affect how health and welfare are distributed is society. The aggregation problem in economic evaluation is certainly not trivial, but is seldom addressed in current practice. This paper shows the underlying assumptions of aggregate cost-benefit analysis (CBA) and cost-effectiveness analysis/cost-utility analysis (CEA/CUA), and it emphasises the particularly strong assumptions which have to be made when QALYs are interpreted as utilities in the welfare economics sense. Naturally, the appropriate method to choose depends on what is to be maximised: welfare or health. If decisions of resource allocation are to be based on economic welfare theory, then CBA should be preferred. However, if QALYs are interpreted as measures of health, rather than as utilities, then CEA/CUA would be appropriate.

Mesh:

Year:  2001        PMID: 11383750     DOI: 10.2165/00019053-200119040-00001

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  30 in total

1.  Is the valuation of a QALY gained independent of age? Some empirical evidence.

Authors:  M Johannesson; P O Johansson
Journal:  J Health Econ       Date:  1997-10       Impact factor: 3.883

2.  A note on the estimation of the equity-efficiency trade-off for QALYs.

Authors:  M Johannesson; U Gerdtham
Journal:  J Health Econ       Date:  1996-06       Impact factor: 3.883

Review 3.  Implications of basing health-care resource allocations on cost-utility analysis in the presence of externalities.

Authors:  R J Labelle; J E Hurley
Journal:  J Health Econ       Date:  1992-10       Impact factor: 3.883

Review 4.  The use of QALYs in health care decision making.

Authors:  G Loomes; L McKenzie
Journal:  Soc Sci Med       Date:  1989       Impact factor: 4.634

5.  QALYs and the equity-efficiency trade-off.

Authors:  A Wagstaff
Journal:  J Health Econ       Date:  1991-05       Impact factor: 3.883

6.  The validity of QALYs: an experimental test of constant proportional tradeoff and utility independence.

Authors:  H Bleichrodt; M Johannesson
Journal:  Med Decis Making       Date:  1997 Jan-Mar       Impact factor: 2.583

Review 7.  Proper preference-based outcome measures in economic evaluations of pharmaceutical interventions.

Authors:  A Gafni
Journal:  Med Care       Date:  1996-12       Impact factor: 2.983

Review 8.  Intergenerational equity: an exploration of the 'fair innings' argument.

Authors:  A Williams
Journal:  Health Econ       Date:  1997 Mar-Apr       Impact factor: 3.046

9.  Assumptions of the QALY procedure.

Authors:  R A Carr-Hill
Journal:  Soc Sci Med       Date:  1989       Impact factor: 4.634

10.  Speech and survival: tradeoffs between quality and quantity of life in laryngeal cancer.

Authors:  B J McNeil; R Weichselbaum; S G Pauker
Journal:  N Engl J Med       Date:  1981-10-22       Impact factor: 91.245

View more
  4 in total

Review 1.  A 'league table' of contingent valuation results for pharmaceutical interventions: a hard pill to swallow?

Authors:  Tracey H Sach; Richard D Smith; David K Whynes
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

Review 2.  Clinical and economic impact of epoetins in cancer care.

Authors:  Monia Marchetti; Giovanni Barosi
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

Review 3.  The impact of economic evaluation on quality management in spine surgery.

Authors:  Norbert Boos
Journal:  Eur Spine J       Date:  2009-04-01       Impact factor: 3.134

4.  Willingness to pay per quality-adjusted life year for life-saving treatments in Thailand.

Authors:  Khachapon Nimdet; Surachat Ngorsuraches
Journal:  BMJ Open       Date:  2015-10-05       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.